Article
19 Apr 2023
A Tale Of Two Lawsuits: Federal Court In Texas Suspends FDA Approval Of Medication Abortion Drug Mifepristone Nationwide, While Federal Court In Washington Orders FDA To Not Alter Availability Of Mifepristone In 17 States And D.C.
United States
Healthcare